Author:
Maleki Ali,Mehrbod Parvaneh,Bokharaei-Salim Farah,Eybpoosh Sana,Tavakoli Mahsa,Mohammadnejad Azita Eshratkhah,Hosseini Zahra,Kashanian Setareh,Asadi Laya Farhan,Salehi-Vaziri Mostafa,Fotouhi Fatemeh
Abstract
Abstract
Background
To improve the patient care, public health surveillance, and infection control, it is crucial to identify the presence and frequency of the common respiratory infections in individuals with COVID-19 symptoms but tested negative for SARS-CoV-2. This study aimed to shed light on this during the COVID-19 pandemic in Iran.
Methods
In this cross-sectional study, a total of 1,002 patients with acute respiratory infection who had negative SARS-CoV-2 test results and referred to Valfajr Health Center, the National Collaborating Laboratory of Influenza and COVID-19 National Reference Laboratory at Pasteur Institute of Iran were recruited between January 2020 and January 2022. Nasopharyngeal and oropharyngeal swab samples were collected to detect 17 common respiratory viruses via TaqMan one-step real-time multiplex PCR. Demographic and clinical data of the participants were obtained from their electronic medical records.
Results
In total, 218 samples (21.8%) were tested positive for at least one respiratory virus infection. Most of the common investigated respiratory viruses belonged to the years 2020 and 2022. The number of investigated patients in 2021 was few, which highlights the impact of health measures following the COVID-19 pandemic in Iran. Influenza A was the most common virus (5.8%), while adenovirus had the lowest prevalence (0.1%). Although the rate of respiratory virus infection was higher in men (24%) compared to women (19.3%), this difference was not statistically significant (P = 0.069). The prevalence of respiratory viruses had an inverse association with increasing age, with the highest rate (55.6%) observed in the age group below 2 years and the lowest rate (12.7%) in those above 65 years.
Conclusion
Our findings underscore the significance of adopting a comprehensive approach to respiratory infections detection and management. These results can be employed for the development of syndromic surveillance systems and implementation of the effective infection control measures. Furthermore, the results contribute to better understanding of the dynamics of respiratory viruses, both during pandemic periods and in non-pandemic contexts.
Funder
Pasteur Institute of Iran
Publisher
Springer Science and Business Media LLC
Subject
Infectious Diseases,Virology
Reference26 articles.
1. Hu B, Guo H, Zhou P, Shi Z-L. Characteristics of SARS-CoV-2 and COVID-19. Nat Rev Microbiol. 2021;19:141–54.
2. The Lancet Respiratory M. COVID-19 transmission-up in the air. Lancet Respir Med. 2020;8:1159.
3. WHO. Modes of transmission of virus causing COVID-19: implications for IPC precaution recommendations, scientific brief. WHO/2019-nCoV/Sci_Brief/Transmission_modes/2020.1 2020.
4. Sapra M, Kirubanandhan S, Kanta P, Ghosh A, Goyal K, Singh MP, et al. Respiratory viral Infections other than SARS CoV-2 among the north Indian patients presenting with acute respiratory Illness during the first COVID-19 wave. VirusDisease. 2022;33:57–64.
5. Wiersinga WJ, Rhodes A, Cheng AC, Peacock SJ, Prescott HC. Pathophysiology, transmission, diagnosis, and treatment of coronavirus Disease 2019 (COVID-19): a review. J Am Med Assoc. 2020;324:782–93.